Spencer Timothy, Domeniconi Marco, Cao Zixuan, Filbin Marie T
Department of Biological Sciences, Hunter College, The City University of New York, 695 Park Avenue, New York, NY 10021, USA.
Curr Opin Neurobiol. 2003 Feb;13(1):133-9. doi: 10.1016/s0959-4388(03)00012-6.
The past year has yielded many insights and a few surprises in the field of axonal regeneration. The identification of oligodendrocyte-myelin glycoprotein as an inhibitor of axonal growth, and the discovery that the three major myelin-associated inhibitors of CNS regeneration share the same functional receptor, has launched a new wave of studies that aim to identify the signaling components of these inhibitory pathways. These findings also offer new avenues of research directed toward blocking possible therapeutic targets that inhibit regeneration and toward encouraging axonal regeneration in the CNS after injury.
过去一年里,轴突再生领域有了许多新见解,也带来了一些惊喜。少突胶质细胞髓鞘糖蛋白被鉴定为轴突生长的抑制剂,并且发现中枢神经系统再生的三种主要髓鞘相关抑制剂共享同一功能受体,这引发了新一轮的研究热潮,旨在确定这些抑制途径的信号传导成分。这些发现还为研究提供了新途径,一方面针对阻断可能抑制再生的治疗靶点,另一方面致力于促进中枢神经系统损伤后轴突的再生。